Re: Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: Results of a randomized phase II neoadjuvant study

Samir S. Taneja

Research output: Contribution to journalEditorialpeer-review

Fingerprint

Dive into the research topics of 'Re: Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: Results of a randomized phase II neoadjuvant study'. Together they form a unique fingerprint.